Inke

Inke is dedicated to the development and manufacture of high-quality APIs, specialized in complex synthesis processes particularly for respiratory therapies. With over 25 years of experience in micronization and based in Barcelona, Spain, Inke has been at the forefront of pharmaceutical innovation since 1980. It is a trusted partner in the global pharmaceutical industry, supplying APIs to markets across Europe, the US, Japan, and more. Inke's commitment to quality and regulatory excellence is reflected in their successful inspections by major global authorities, including the US-FDA, with their most recent inspection in April 2019. The company's portfolio reflects a deep commitment to innovation, patent leadership, and scientific excellence in the pharmaceutical field. It develops, patents, and implements its synthesis routes, ensuring compliance with stringent regulatory requirements and delivering tailor-made solutions for customers. In addition to micronization expertise, Inke provides comprehensive support for the regulatory process, including Drug Master Files (DMFs), Certificates of Suitability (CEPs), and full technical assistance. Inke's R&D initiatives and advanced laboratory facilities make it a leading player in the respiratory therapeutics space, always pushing boundaries to meet customer and patient needs. For more information about Inke's expertise in inhalation therapies, interested parties can contact them via email at [email protected].